Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)

The Regenerative Medicine Innovation Project (RMIP) funds scientists and doctors to test new medical treatments that can help the body heal or replace damaged tissue. This funding is for investigator-initiated clinical trials, which means the researcher comes up with the study idea, designs it, and leads the trial. Only trials that are already planned to include UH3 clinical testing are eligible. The goal is to support innovative experiments that could lead to real treatments for patients, while giving researchers the resources to carefully study safety and effectiveness in a clinical setting.